The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 27, 2012
Filed:
Jul. 03, 2007
Istvan Gacsalyi, Budapest, HU;
Gabor Gigler, Budapest, HU;
Marta Agoston, Budapest, HU;
Hajnalka Kompagne, Budapest, HU;
Szabolcs Kertesz, Fót, HU;
Krisztina Moricz, Budapest, HU;
Gyoergy Levay, Budapest, HU;
Gabor Szenas, Ueroem, HU;
Lászlo Gabor Harsing, Budapest, HU;
Jozsef Barkoczy, Budapest, HU;
Gyula Simig, Budapest, HU;
Istvan Gacsalyi, Budapest, HU;
Gabor Gigler, Budapest, HU;
Marta Agoston, Budapest, HU;
Hajnalka Kompagne, Budapest, HU;
Szabolcs Kertesz, Fót, HU;
Krisztina Moricz, Budapest, HU;
Gyoergy Levay, Budapest, HU;
Gabor Szenas, Ueroem, HU;
Lászlo Gabor Harsing, Budapest, HU;
Jozsef Barkoczy, Budapest, HU;
Gyula Simig, Budapest, HU;
Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag, Budapest, HU;
Abstract
The invention relates the use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazole-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone of the Formula (I) or pharmaceutically acceptable salts thereof for the preparation of medicaments suitable for the improvement of cognitive function or obtaining neuroprotective effect. The medicaments containing 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazol-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone of the Formula (I) or therapeutically acceptable salt thereof can be used for the treatment or prevention of neuronal death, mental decline, sclerosis multiplex, Creuzfeld-Jacobs disease, Huntington-syndrome, amyotrophic lateral sclerosis, Parkinson-disease, memory disturbance, loss of memory, amnesia, stroke or for the improvement of memory function or learning ability.